IFP Advisors’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
IFP Advisors's KALV Position: Q3 2026 in Review
IFP Advisors sold out of KalVista Pharmaceuticals (KALV) in Q3 2026, closing a stake of 7 shares — an estimated $189 sold.
IFP Advisors first reported a position in KALV in Q4 2024 and held it in 4 quarters. The position peaked at $189 in Q2 2026. 0 funds tracked by Wall St. Rank hold KALV as of Q3 2026.
- IFP Advisors reported no remaining KalVista Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- IFP Advisors sold 7 KalVista Pharmaceuticals shares in Q3 2026, an estimated $189.
- IFP Advisors first reported a position in KalVista Pharmaceuticals in Q4 2024 and held it in 4 quarters.
- IFP Advisors's KalVista Pharmaceuticals position peaked at $189 in Q2 2026.
- 0 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q3 2026.
Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.